SlideShare a Scribd company logo
1 of 1
Kinetics of Human β3 Alcohol Dehydrogenase
Joshua Benton, Jennifer Chase, Ph.D. (Department of Biology)
Alcohol-related diseases have been observed to predominate in specific people groups while
appearing suppressed in others. Multiple genetic polymorphisms exist for the alcohol
dehydrogenase (ADH) enzyme and are responsible for the unique tolerance level of each people
group to developing alcohol-related diseases. ADH is largely responsible for ethanol
metabolism in the body. High alcohol consumption in humans results in elevated ethanol levels
and can cause disease (i.e. fetal alcohol syndrome) if not effectively metabolized. It is
hypothesized that ethanol competitively inhibits the oxidation of retinol, slowing the production
of retinoic acid and ultimately deregulating cell growth. The β₃β₃ isoform of the ADH enzyme
has been said to be protective against alcohol-related diseases by oxidizing ethanol at a faster
rate than other ADH isoforms. African-Americans have been found to predominantly possess
the ADH1B3 gene that codes for the β₃β₃ ADH enzyme. Almost no literature data has
determine the kinetic properties of β₃β₃ ADH with appropriate consideration for physiological
conditions. A complete set of methodologically sound kinetic studies of β₃β₃ ADH are needed
for correctly understanding its suppression of disease. The goal was to not only verify the
hypothesized ethanol inhibition of retinol oxidation but to also investigate temperature's effect on
the determination of the kinetic constants needed to assess ethanol inhibition. Recombinant
enzyme was isolated and two kinetic studies were performed, first with varied ethanol and NAD+
substrate concentrations and second with varied acetaldehyde and NADH. Both studies were
performed at 25ºC and 37ºC. Data suggests that temperature only has a significant effect when
β₃β₃ ADH is catalyzing the oxidation of acetaldehyde. Results also indicate that β₃β₃ ADH
binds in the forward direction via an ordered bi-bi mechanism. In order to resolutely determine
ethanol inhibition of retinol oxidation, further kinetic studies with other substrates of varied
concentration and temperature (25ºC and 37ºC) are needed.

More Related Content

Similar to INBRE Research Abstract

2011. lactate biomarker and potential therapeutic target
2011. lactate   biomarker and potential therapeutic target2011. lactate   biomarker and potential therapeutic target
2011. lactate biomarker and potential therapeutic target
Flores Hdz
 
Lab test and treatment od addison's disease
Lab test and treatment od addison's diseaseLab test and treatment od addison's disease
Lab test and treatment od addison's disease
eman youssif
 
DamonPhamFINALPoster
DamonPhamFINALPosterDamonPhamFINALPoster
DamonPhamFINALPoster
Damon Pham
 
ACS Med Chem 2011 (2) 919-923
ACS Med Chem 2011 (2) 919-923ACS Med Chem 2011 (2) 919-923
ACS Med Chem 2011 (2) 919-923
Dinesh Barawkar
 
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
Abigail Coleman
 

Similar to INBRE Research Abstract (20)

FXR ADH1
FXR ADH1FXR ADH1
FXR ADH1
 
i29.full
i29.fulli29.full
i29.full
 
2011. lactate biomarker and potential therapeutic target
2011. lactate   biomarker and potential therapeutic target2011. lactate   biomarker and potential therapeutic target
2011. lactate biomarker and potential therapeutic target
 
Synthetic antiauxins
Synthetic antiauxinsSynthetic antiauxins
Synthetic antiauxins
 
Lab test and treatment od addison's disease
Lab test and treatment od addison's diseaseLab test and treatment od addison's disease
Lab test and treatment od addison's disease
 
Liver enzymes in normal and sickle cell
Liver enzymes in normal and sickle cellLiver enzymes in normal and sickle cell
Liver enzymes in normal and sickle cell
 
HDAC11, A New Target For Cancer.pptx
HDAC11, A New Target For Cancer.pptxHDAC11, A New Target For Cancer.pptx
HDAC11, A New Target For Cancer.pptx
 
Environmental Health Perspectives
Environmental Health PerspectivesEnvironmental Health Perspectives
Environmental Health Perspectives
 
DamonPhamFINALPoster
DamonPhamFINALPosterDamonPhamFINALPoster
DamonPhamFINALPoster
 
Genetics differences affect drug metabolism
Genetics differences affect drug metabolismGenetics differences affect drug metabolism
Genetics differences affect drug metabolism
 
Kenyatta university acth biuretic test
Kenyatta university acth biuretic testKenyatta university acth biuretic test
Kenyatta university acth biuretic test
 
Cholinesterase
CholinesteraseCholinesterase
Cholinesterase
 
Halliwell et al., am. j. clin. nutr. 2005 health promotiion by flavonoids, to...
Halliwell et al., am. j. clin. nutr. 2005 health promotiion by flavonoids, to...Halliwell et al., am. j. clin. nutr. 2005 health promotiion by flavonoids, to...
Halliwell et al., am. j. clin. nutr. 2005 health promotiion by flavonoids, to...
 
ACS Med Chem 2011 (2) 919-923
ACS Med Chem 2011 (2) 919-923ACS Med Chem 2011 (2) 919-923
ACS Med Chem 2011 (2) 919-923
 
DM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACCDM Garby_Synthetic Cannabinoids_ 2015 AACC
DM Garby_Synthetic Cannabinoids_ 2015 AACC
 
Seminario molecular
Seminario molecularSeminario molecular
Seminario molecular
 
Seminario final 97
Seminario final 97Seminario final 97
Seminario final 97
 
Updates in managment of acute poisoned patient
Updates in managment of acute poisoned patientUpdates in managment of acute poisoned patient
Updates in managment of acute poisoned patient
 
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
In-vitro-anti-cholinesterase-activities-by-piperine-an-alkaloid-from-the-spic...
 
Rehmat ullah assignment
Rehmat ullah assignmentRehmat ullah assignment
Rehmat ullah assignment
 

INBRE Research Abstract

  • 1. Kinetics of Human β3 Alcohol Dehydrogenase Joshua Benton, Jennifer Chase, Ph.D. (Department of Biology) Alcohol-related diseases have been observed to predominate in specific people groups while appearing suppressed in others. Multiple genetic polymorphisms exist for the alcohol dehydrogenase (ADH) enzyme and are responsible for the unique tolerance level of each people group to developing alcohol-related diseases. ADH is largely responsible for ethanol metabolism in the body. High alcohol consumption in humans results in elevated ethanol levels and can cause disease (i.e. fetal alcohol syndrome) if not effectively metabolized. It is hypothesized that ethanol competitively inhibits the oxidation of retinol, slowing the production of retinoic acid and ultimately deregulating cell growth. The β₃β₃ isoform of the ADH enzyme has been said to be protective against alcohol-related diseases by oxidizing ethanol at a faster rate than other ADH isoforms. African-Americans have been found to predominantly possess the ADH1B3 gene that codes for the β₃β₃ ADH enzyme. Almost no literature data has determine the kinetic properties of β₃β₃ ADH with appropriate consideration for physiological conditions. A complete set of methodologically sound kinetic studies of β₃β₃ ADH are needed for correctly understanding its suppression of disease. The goal was to not only verify the hypothesized ethanol inhibition of retinol oxidation but to also investigate temperature's effect on the determination of the kinetic constants needed to assess ethanol inhibition. Recombinant enzyme was isolated and two kinetic studies were performed, first with varied ethanol and NAD+ substrate concentrations and second with varied acetaldehyde and NADH. Both studies were performed at 25ºC and 37ºC. Data suggests that temperature only has a significant effect when β₃β₃ ADH is catalyzing the oxidation of acetaldehyde. Results also indicate that β₃β₃ ADH binds in the forward direction via an ordered bi-bi mechanism. In order to resolutely determine ethanol inhibition of retinol oxidation, further kinetic studies with other substrates of varied concentration and temperature (25ºC and 37ºC) are needed.